Elevance Health (ELV)

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-06-12 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: Elevance Health, Inc. (ELV) CIK: 0001156039 --- Reporting Owner --- Name: Penczek Ronald W CIK: 0001659075 Role: Officer (CAO & Controller) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-06-12 | Code: S (Open market sale) Shares: -369 | Price: $403.16 Total Value: $148,766.04 Shares Owned After: 3,740 | Ownership: D (Direct) Footnotes: [F1] This transaction was executed in multiple trades at prices ranging from $403.15 to $403.31. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. --- Footnotes (Complete Index) --- F1: This transaction was executed in multiple trades at prices ranging from $403.15 to $403.31. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. --- Signature --- /s/ /s/ Kathleen S. Kiefer, Attorney in fact (2026-06-15)